Annual EBITDA
-$8.35 M
+$12.59 M+60.14%
01 July 2024
Summary:
Enzo Biochem annual earnings before interest, taxes, depreciation & amortization is currently -$8.35 million, with the most recent change of +$12.59 million (+60.14%) on 01 July 2024. During the last 3 years, it has fallen by -$11.69 million (-349.57%). ENZ annual EBITDA is now -172.71% below its all-time high of $11.48 million, reached on 31 July 2001.ENZ EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$2.05 M
-$1.03 M-102.07%
01 July 2024
Summary:
Enzo Biochem quarterly earnings before interest, taxes, depreciation & amortization is currently -$2.05 million, with the most recent change of -$1.03 million (-102.07%) on 01 July 2024. Over the past year, it has increased by +$2.08 million (+50.40%). ENZ quarterly EBITDA is now -132.92% below its all-time high of $6.22 million, reached on 31 October 2002.ENZ Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$8.35 M
+$9.60 M+53.49%
01 July 2024
Summary:
Enzo Biochem TTM earnings before interest, taxes, depreciation & amortization is currently -$8.35 million, with the most recent change of +$9.60 million (+53.49%) on 01 July 2024. Over the past year, it has increased by +$13.90 million (+62.47%). ENZ TTM EBITDA is now -155.15% below its all-time high of $15.14 million, reached on 31 January 2003.ENZ TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.1% | +50.4% | +62.5% |
| 3 y3 years | -349.6% | -1457.0% | -591.5% |
| 5 y5 years | +60.5% | +64.6% | +63.7% |
ENZ EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -349.6% | +60.1% | -225.9% | +82.4% | -591.5% | +62.5% |
| 5 y | 5 years | -349.6% | +69.7% | -144.2% | +82.4% | -349.7% | +69.7% |
| alltime | all time | -172.7% | +69.7% | -132.9% | +82.4% | -155.2% | +69.7% |
Enzo Biochem EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | -$8.35 M(-60.1%) | -$2.05 M(+102.1%) | -$8.35 M(-53.5%) |
| Apr 2024 | - | -$1.01 M(-12.4%) | -$17.95 M(-11.9%) |
| Jan 2024 | - | -$1.16 M(-72.0%) | -$20.38 M(-8.4%) |
| Oct 2023 | - | -$4.13 M(-64.5%) | -$22.25 M(+6.3%) |
| July 2023 | -$20.94 M(+126.0%) | -$11.65 M(+238.8%) | -$20.94 M(+12.2%) |
| Apr 2023 | - | -$3.44 M(+13.5%) | -$18.66 M(+10.5%) |
| Jan 2023 | - | -$3.03 M(+7.5%) | -$16.89 M(+38.1%) |
| Oct 2022 | - | -$2.82 M(-69.9%) | -$12.24 M(+32.1%) |
| July 2022 | -$9.27 M(-377.0%) | -$9.37 M(+461.3%) | -$9.27 M(+36.6%) |
| Apr 2022 | - | -$1.67 M(-202.6%) | -$6.78 M(+417.3%) |
| Jan 2022 | - | $1.63 M(+977.5%) | -$1.31 M(-177.2%) |
| Oct 2021 | - | $151.00 K(-102.2%) | $1.70 M(-49.2%) |
| July 2021 | $3.35 M(-112.1%) | -$6.89 M(-281.3%) | $3.35 M(+344.8%) |
| Apr 2021 | - | $3.80 M(-18.0%) | $752.00 K(-107.4%) |
| Jan 2021 | - | $4.64 M(+158.0%) | -$10.13 M(-49.4%) |
| Oct 2020 | - | $1.80 M(-118.9%) | -$20.01 M(-27.5%) |
| July 2020 | -$27.59 M(+30.4%) | -$9.48 M(+33.9%) | -$27.59 M(+21.0%) |
| Apr 2020 | - | -$7.08 M(+35.2%) | -$22.80 M(+7.1%) |
| Jan 2020 | - | -$5.24 M(-9.4%) | -$21.28 M(-7.6%) |
| Oct 2019 | - | -$5.78 M(+23.0%) | -$23.03 M(+8.8%) |
| July 2019 | -$21.16 M(+441.5%) | -$4.70 M(-15.5%) | -$21.16 M(+5.6%) |
| Apr 2019 | - | -$5.56 M(-20.4%) | -$20.04 M(+35.3%) |
| Jan 2019 | - | -$6.98 M(+78.5%) | -$14.81 M(+77.2%) |
| Oct 2018 | - | -$3.91 M(+9.0%) | -$8.36 M(+114.0%) |
| July 2018 | -$3.91 M(-283.5%) | -$3.59 M(+980.4%) | -$3.91 M(-945.7%) |
| Apr 2018 | - | -$332.00 K(-37.4%) | $462.00 K(-75.6%) |
| Jan 2018 | - | -$530.00 K(-197.8%) | $1.90 M(-28.4%) |
| Oct 2017 | - | $542.00 K(-30.7%) | $2.65 M(+24.5%) |
| July 2017 | $2.13 M(-1296.1%) | $782.00 K(-29.1%) | $2.13 M(+39.0%) |
| Apr 2017 | - | $1.10 M(+394.6%) | $1.53 M(+202.2%) |
| Jan 2017 | - | $223.00 K(+961.9%) | $507.00 K(-193.0%) |
| Oct 2016 | - | $21.00 K(-88.6%) | -$545.00 K(+206.2%) |
| July 2016 | -$178.00 K(+104.6%) | $185.00 K(+137.2%) | -$178.00 K(-63.7%) |
| Apr 2016 | - | $78.00 K(-109.4%) | -$491.00 K(-30.5%) |
| Jan 2016 | - | -$829.00 K(-313.7%) | -$706.00 K(+3615.8%) |
| Oct 2015 | - | $388.00 K(-403.1%) | -$19.00 K(-78.2%) |
| July 2015 | -$87.00 K(-96.3%) | -$128.00 K(-6.6%) | -$87.00 K(-179.1%) |
| Apr 2015 | - | -$137.00 K(-3.5%) | $110.00 K(-121.6%) |
| Jan 2015 | - | -$142.00 K(-144.4%) | -$509.00 K(-64.2%) |
| Oct 2014 | - | $320.00 K(+363.8%) | -$1.42 M(-39.6%) |
| July 2014 | -$2.35 M(-72.5%) | $69.00 K(-109.1%) | -$2.36 M(-37.1%) |
| Apr 2014 | - | -$756.00 K(-28.3%) | -$3.74 M(-34.6%) |
| Jan 2014 | - | -$1.05 M(+71.8%) | -$5.73 M(-28.7%) |
| Oct 2013 | - | -$614.00 K(-53.4%) | -$8.04 M(-6.1%) |
| July 2013 | -$8.56 M(+10.6%) | -$1.32 M(-51.9%) | -$8.56 M(-9.0%) |
| Apr 2013 | - | -$2.74 M(-18.6%) | -$9.41 M(+14.5%) |
| Jan 2013 | - | -$3.37 M(+196.6%) | -$8.22 M(+24.6%) |
| Oct 2012 | - | -$1.14 M(-47.6%) | -$6.60 M(-23.3%) |
| July 2012 | -$7.74 M(+62.9%) | -$2.17 M(+39.6%) | -$8.60 M(+55.2%) |
| Apr 2012 | - | -$1.55 M(-11.0%) | -$5.54 M(+7.7%) |
| Jan 2012 | - | -$1.74 M(-44.5%) | -$5.15 M(-34.8%) |
| Oct 2011 | - | -$3.14 M(-451.6%) | -$7.89 M(+66.1%) |
| July 2011 | -$4.75 M(-73.3%) | $893.00 K(-177.2%) | -$4.75 M(-66.5%) |
| Apr 2011 | - | -$1.16 M(-74.2%) | -$14.19 M(-12.7%) |
| Jan 2011 | - | -$4.49 M(<-9900.0%) | -$16.26 M(-3.6%) |
| Oct 2010 | - | $1000.00(-100.0%) | -$16.87 M(-5.2%) |
| July 2010 | -$17.79 M(+12.9%) | -$8.54 M(+164.4%) | -$17.79 M(+38.5%) |
| Apr 2010 | - | -$3.23 M(-36.7%) | -$12.84 M(+4.9%) |
| Jan 2010 | - | -$5.10 M(+454.2%) | -$12.24 M(-2.4%) |
| Oct 2009 | - | -$920.00 K(-74.4%) | -$12.54 M(-26.5%) |
| July 2009 | -$15.75 M(+24.6%) | -$3.59 M(+36.5%) | -$17.06 M(+1.9%) |
| Apr 2009 | - | -$2.63 M(-51.3%) | -$16.75 M(+2.4%) |
| Jan 2009 | - | -$5.40 M(-0.8%) | -$16.36 M(+4.2%) |
| Oct 2008 | - | -$5.44 M(+65.7%) | -$15.69 M(+24.2%) |
| July 2008 | -$12.64 M(-36.1%) | -$3.28 M(+46.7%) | -$12.64 M(-8.9%) |
| Apr 2008 | - | -$2.24 M(-52.8%) | -$13.87 M(-16.8%) |
| Jan 2008 | - | -$4.74 M(+98.7%) | -$16.67 M(-9.0%) |
| Oct 2007 | - | -$2.38 M(-47.2%) | -$18.32 M(-7.4%) |
| July 2007 | -$19.78 M(+3.9%) | -$4.51 M(-10.3%) | -$19.78 M(-5.2%) |
| Apr 2007 | - | -$5.04 M(-21.2%) | -$20.86 M(+3.4%) |
| Jan 2007 | - | -$6.39 M(+66.3%) | -$20.17 M(+4.6%) |
| Oct 2006 | - | -$3.84 M(-31.4%) | -$19.28 M(+1.3%) |
| July 2006 | -$19.03 M(+138.6%) | -$5.60 M(+28.7%) | -$19.03 M(+14.0%) |
| Apr 2006 | - | -$4.35 M(-20.9%) | -$16.69 M(+13.6%) |
| Jan 2006 | - | -$5.50 M(+53.1%) | -$14.69 M(+47.0%) |
| Oct 2005 | - | -$3.59 M(+10.1%) | -$9.99 M(+25.4%) |
| July 2005 | -$7.97 M(-19.2%) | -$3.26 M(+39.1%) | -$7.97 M(-26.9%) |
| Apr 2005 | - | -$2.35 M(+193.1%) | -$10.91 M(+18.9%) |
| Jan 2005 | - | -$800.00 K(-48.9%) | -$9.17 M(-15.1%) |
| Oct 2004 | - | -$1.57 M(-74.7%) | -$10.80 M(+9.4%) |
| July 2004 | -$9.87 M | -$6.20 M(+917.7%) | -$9.87 M(+19.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2004 | - | -$609.00 K(-74.9%) | -$8.28 M(+48.1%) |
| Jan 2004 | - | -$2.43 M(+282.2%) | -$5.59 M(+720.4%) |
| Oct 2003 | - | -$635.00 K(-86.2%) | -$681.70 K(-111.0%) |
| July 2003 | $6.18 M(-44.6%) | -$4.61 M(-321.7%) | $6.18 M(-51.2%) |
| Apr 2003 | - | $2.08 M(-16.3%) | $12.65 M(-16.5%) |
| Jan 2003 | - | $2.48 M(-60.1%) | $15.14 M(+6.7%) |
| Oct 2002 | - | $6.22 M(+234.7%) | $14.19 M(+27.3%) |
| July 2002 | $11.14 M(-2.9%) | $1.86 M(-59.3%) | $11.14 M(-10.3%) |
| Apr 2002 | - | $4.57 M(+198.9%) | $12.42 M(+12.6%) |
| Jan 2002 | - | $1.53 M(-51.9%) | $11.03 M(-8.1%) |
| Oct 2001 | - | $3.18 M(+1.5%) | $12.00 M(+4.5%) |
| July 2001 | $11.48 M(+63.8%) | $3.13 M(-1.6%) | $11.48 M(+9.0%) |
| Apr 2001 | - | $3.18 M(+27.3%) | $10.54 M(+13.9%) |
| Jan 2001 | - | $2.50 M(-5.9%) | $9.25 M(+13.5%) |
| Oct 2000 | - | $2.66 M(+21.4%) | $8.15 M(+16.6%) |
| July 2000 | $7.01 M(+34.8%) | $2.19 M(+15.2%) | $6.99 M(+13.1%) |
| Apr 2000 | - | $1.90 M(+35.8%) | $6.18 M(+5.2%) |
| Jan 2000 | - | $1.40 M(-6.7%) | $5.88 M(-1.7%) |
| Oct 1999 | - | $1.50 M(+8.5%) | $5.97 M(+17.7%) |
| July 1999 | $5.20 M(+92.6%) | $1.38 M(-13.2%) | $5.08 M(+18.2%) |
| Apr 1999 | - | $1.59 M(+6.2%) | $4.29 M(+10.1%) |
| Jan 1999 | - | $1.50 M(+150.0%) | $3.90 M(+39.3%) |
| Oct 1998 | - | $600.00 K(0.0%) | $2.80 M(+3.7%) |
| July 1998 | $2.70 M(+80.0%) | $600.00 K(-50.0%) | $2.70 M(-22.9%) |
| Apr 1998 | - | $1.20 M(+200.0%) | $3.50 M(+34.6%) |
| Jan 1998 | - | $400.00 K(-20.0%) | $2.60 M(+23.8%) |
| Oct 1997 | - | $500.00 K(-64.3%) | $2.10 M(+40.0%) |
| July 1997 | $1.50 M(+400.0%) | $1.40 M(+366.7%) | $1.50 M(-129.4%) |
| Apr 1997 | - | $300.00 K(-400.0%) | -$5.10 M(+45.7%) |
| Jan 1997 | - | -$100.00 K(0.0%) | -$3.50 M(+40.0%) |
| Oct 1996 | - | -$100.00 K(-98.1%) | -$2.50 M(+150.0%) |
| July 1996 | $300.00 K(+200.0%) | -$5.20 M(-373.7%) | -$1.00 M(-147.6%) |
| Apr 1996 | - | $1.90 M(+111.1%) | $2.10 M(+250.0%) |
| Jan 1996 | - | $900.00 K(-35.7%) | $600.00 K(-33.3%) |
| Oct 1995 | - | $1.40 M(-166.7%) | $900.00 K(+50.0%) |
| July 1995 | $100.00 K(-90.9%) | -$2.10 M(-625.0%) | $600.00 K(-79.3%) |
| Apr 1995 | - | $400.00 K(-66.7%) | $2.90 M(+7.4%) |
| Jan 1995 | - | $1.20 M(+9.1%) | $2.70 M(+92.9%) |
| Oct 1994 | - | $1.10 M(+450.0%) | $1.40 M(+27.3%) |
| July 1994 | $1.10 M(-130.6%) | $200.00 K(0.0%) | $1.10 M(-128.2%) |
| Apr 1994 | - | $200.00 K(-300.0%) | -$3.90 M(0.0%) |
| Jan 1994 | - | -$100.00 K(-112.5%) | -$3.90 M(+14.7%) |
| Oct 1993 | - | $800.00 K(-116.7%) | -$3.40 M(-5.6%) |
| July 1993 | -$3.60 M(-357.1%) | -$4.80 M(-2500.0%) | -$3.60 M(-614.3%) |
| Apr 1993 | - | $200.00 K(-50.0%) | $700.00 K(-30.0%) |
| Jan 1993 | - | $400.00 K(-33.3%) | $1.00 M(-23.1%) |
| Oct 1992 | - | $600.00 K(-220.0%) | $1.30 M(-7.1%) |
| July 1992 | $1.40 M(-200.0%) | -$500.00 K(-200.0%) | $1.40 M(-44.0%) |
| Apr 1992 | - | $500.00 K(-28.6%) | $2.50 M(+127.3%) |
| Jan 1992 | - | $700.00 K(0.0%) | $1.10 M(-375.0%) |
| Oct 1991 | - | $700.00 K(+16.7%) | -$400.00 K(-73.3%) |
| July 1991 | -$1.40 M(-12.5%) | $600.00 K(-166.7%) | -$1.50 M(-25.0%) |
| Apr 1991 | - | -$900.00 K(+12.5%) | -$2.00 M(+11.1%) |
| Jan 1991 | - | -$800.00 K(+100.0%) | -$1.80 M(-5.3%) |
| Oct 1990 | - | -$400.00 K(-500.0%) | -$1.90 M(+18.8%) |
| July 1990 | -$1.60 M(-56.8%) | $100.00 K(-114.3%) | -$1.60 M(-87.2%) |
| Apr 1990 | - | -$700.00 K(-22.2%) | -$12.50 M(+33.0%) |
| Jan 1990 | - | -$900.00 K(+800.0%) | -$9.40 M(+49.2%) |
| Oct 1989 | - | -$100.00 K(-99.1%) | -$6.30 M(+57.5%) |
| July 1989 | -$3.70 M(+54.2%) | -$10.80 M(-550.0%) | -$4.00 M(+42.9%) |
| Apr 1989 | - | $2.40 M(+9.1%) | -$2.80 M(0.0%) |
| Jan 1989 | - | $2.20 M(0.0%) | -$2.80 M(0.0%) |
| Oct 1988 | - | $2.20 M(-122.9%) | -$2.80 M(-3.4%) |
| July 1988 | -$2.40 M(-7.7%) | -$9.60 M(-500.0%) | -$2.90 M(0.0%) |
| Apr 1988 | - | $2.40 M(+9.1%) | -$2.90 M(-6.5%) |
| Jan 1988 | - | $2.20 M(+4.8%) | -$3.10 M(0.0%) |
| Oct 1987 | - | $2.10 M(-121.9%) | -$3.10 M(0.0%) |
| July 1987 | -$2.60 M(-285.7%) | -$9.60 M(-536.4%) | -$3.10 M(-196.9%) |
| Apr 1987 | - | $2.20 M(0.0%) | $3.20 M(+6.7%) |
| Jan 1987 | - | $2.20 M(+4.8%) | $3.00 M(+87.5%) |
| Oct 1986 | - | $2.10 M(-163.6%) | $1.60 M(+45.5%) |
| July 1986 | $1.40 M(+55.6%) | -$3.30 M(-265.0%) | $1.10 M(+120.0%) |
| Apr 1986 | - | $2.00 M(+150.0%) | $500.00 K(+25.0%) |
| Jan 1986 | - | $800.00 K(-50.0%) | $400.00 K(-63.6%) |
| Oct 1985 | - | $1.60 M(-141.0%) | $1.10 M(+57.1%) |
| July 1985 | $900.00 K(+12.5%) | -$3.90 M(-305.3%) | $700.00 K(-74.1%) |
| Apr 1985 | - | $1.90 M(+26.7%) | $2.70 M(+68.8%) |
| Jan 1985 | - | $1.50 M(+25.0%) | $1.60 M(+60.0%) |
| Oct 1984 | - | $1.20 M(-163.2%) | $1.00 M(-600.0%) |
| July 1984 | $800.00 K | -$1.90 M(-337.5%) | -$200.00 K(-111.8%) |
| Apr 1984 | - | $800.00 K(-11.1%) | $1.70 M(+88.9%) |
| Jan 1984 | - | $900.00 K | $900.00 K |
FAQ
- What is Enzo Biochem annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Enzo Biochem?
- What is Enzo Biochem annual EBITDA year-on-year change?
- What is Enzo Biochem quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Enzo Biochem?
- What is Enzo Biochem quarterly EBITDA year-on-year change?
- What is Enzo Biochem TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Enzo Biochem?
- What is Enzo Biochem TTM EBITDA year-on-year change?
What is Enzo Biochem annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ENZ is -$8.35 M
What is the all time high annual EBITDA for Enzo Biochem?
Enzo Biochem all-time high annual earnings before interest, taxes, depreciation & amortization is $11.48 M
What is Enzo Biochem annual EBITDA year-on-year change?
Over the past year, ENZ annual earnings before interest, taxes, depreciation & amortization has changed by +$12.59 M (+60.14%)
What is Enzo Biochem quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ENZ is -$2.05 M
What is the all time high quarterly EBITDA for Enzo Biochem?
Enzo Biochem all-time high quarterly earnings before interest, taxes, depreciation & amortization is $6.22 M
What is Enzo Biochem quarterly EBITDA year-on-year change?
Over the past year, ENZ quarterly earnings before interest, taxes, depreciation & amortization has changed by +$2.08 M (+50.40%)
What is Enzo Biochem TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ENZ is -$8.35 M
What is the all time high TTM EBITDA for Enzo Biochem?
Enzo Biochem all-time high TTM earnings before interest, taxes, depreciation & amortization is $15.14 M
What is Enzo Biochem TTM EBITDA year-on-year change?
Over the past year, ENZ TTM earnings before interest, taxes, depreciation & amortization has changed by +$13.90 M (+62.47%)